Evozyne (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- September 29, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $81,000,000
Company Info
- Company Description
- Evozyne combines evolution and deep learning technology to create highly functional novel proteins - Natural Machines - to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein's function based on the rules of nature, we address complex, high-impact problems.
- Market
- Therapeutics and Sustainability
- Location
- Chicago, IL, USA
- Coinvestors
- Fidelity Management & Research Company, NVentures, OrbiMed US, Paragon Biosciences, Valor Equity Partners